INTRODUCTION For women with a BRCA1 or BRCA2 mutation or a strong family history of breast cancer, there is no clear estimation of the risk of tumour induction versus the beneficial effects of mammography screening available. This study aims to validate the Simulation Model on Radiation Risk and breast cancer Screening (SiMRiSc) model in these women, which can provide information on the benefit...

INTRODUCTION The aim of this study was to investigate the utilization of breast, colon and prostate cancer screening in the adult Croatian population in a period without national cancer screening programs, with a special interest in respondents' rural versus urban origin. METHODS Self-reported screening utilization was investigated in the Croatian Adult Health Survey, which collected health-r...

In October 2015, the American Cancer Society (ACS) updated its evidence-based breast cancer screening guidelines for women at average risk for breast cancer. These guidelines introduced significant changes to the age to begin breast cancer screening, as well as the frequency between screenings and duration of screening. Not long afterward, in January 2016, the U.S. Preventive Services Task Forc...

The societal value of mammographic screening in women 40-49 years old is a controversial topic that is subject as much to emotional rhetoric as to scientific insight. This controversy is reflected in part in differences in screening guidelines developed by professional, voluntary, and government organizations. Early results from epidemiologic studies did not demonstrate conclusively that mammog...

Submit Manuscript | http://medcraveonline.com countries. According to the statistics (Figure 2), the rate of early stage (stages 0-2) breast cancer cases diagnosed by screening was 86%, whereas the rate of those not diagnosed by screening was 56%. Regular screening assists in recognizing early stage of breast cancer, and early treatment increases the remission rate, therefore, the five-year sur...

background: although multifocal and multicentric breast cancers are a common entity, their clinical behavior is not well characterized. with the widespread use of mammographic screening and improved sensitivity of imaging modalities, the detection of multifocal and multicentric breast cancers is likely to continuously increase. many studies have consistently shown a correlation between multifoc...

PURPOSE/OBJECTIVES To describe perceived breast cancer risk, identify the percentage of women with inaccurate risk perceptions, and examine the influence of perceived and objective risk on screening behavior. DESIGN Descriptive, correlational, cross-sectional. SETTING Community settings in a metropolitan area on the western coast of the United States. SAMPLE Multicultural sample of 184 En...

Breast cancer screening remains a subject of intense and, at times, passionate debate. Mammography has long been the mainstay of breast cancer detection and is the only screening test proven to reduce mortality. Although it remains the gold standard of breast cancer screening, there is increasing awareness of subpopulations of women for whom mammography has reduced sensitivity. Mammography has ...

Breast cancer is the most common non-skin cancer and the second leading cause of cancer death in North American women. Mammography is the only screening test shown to reduce breast cancer-related mortality. There is general agreement that screening should be offered at least biennially to women 50 to 74 years of age. For women 40 to 49 years of age, the risks and benefits of screening should be...